Delayed CIN2 treatment does not increase cancer risk
1. In this target trial emulation, delayed treatment of cervical intraepithelial neoplasia grade 2 (CIN 2) was associated with a ...
1. In this target trial emulation, delayed treatment of cervical intraepithelial neoplasia grade 2 (CIN 2) was associated with a ...
1. In this cohort study, the quadrivalent human papillomavirus (HPV) vaccine provides strong, long-lasting protection against invasive cervical cancer, with ...
Extended follow-up of invasive cervical cancer risk after quadrivalent HPV vaccination: nationwide, register based study 1. In this cohort study, ...
1. Glucagon-like peptide-1 receptor agonists (GLP-1RA) in combination with progestins are significantly more effective at reducing endometrial cancer (EC) risk ...
1. Across the premenopausal and postmenopausal groups, early menarche, later menopause, and longer reproductive span were associated with higher ovarian ...
Reproductive Shifts and Ovarian Cancer Risk in Women Aged 40 Years or Older 1. Across the premenopausal and postmenopausal groups, ...
1. This cohort study found that the IOTA ADNEX ultrasound model at a 10% risk threshold detected more ovarian cancers ...
1. In this cohort study, patients with early-stage, low-grade endometrial cancer who did not undergo hysterectomy, specifically those from racial ...
1. Progression-free and overall survival were greater in relacorilant plus nab-paclitaxel compared to nab-paclitaxel alone. 2. The rate of adverse ...
1. A history of endometriosis and uterine fibroids in women was associated with a greater risk of premature mortality ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.